alisol b has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, F; Li, H; Li, L; Lu, Q; Wang, Q; Xie, C; Xiong, W; Yang, L; Zhao, A | 1 |
| Dias, DA; Gill, H; Hung, A; Lenon, GB; Li, M; Luo, S; Nguyen, LT | 1 |
2 other study(ies) available for alisol b and Obesity
| Article | Year |
|---|---|
Alisol B blocks the development of HFD-induced obesity by triggering the LKB1-AMPK signaling in subcutaneous adipose tissue.
Topics: Adipogenesis; Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cholestenones; Diet, High-Fat; Mice; Mice, Inbred C57BL; Obesity; Subcutaneous Fat | 2023 |
Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches.
Topics: Animals; Anti-Obesity Agents; Carbohydrate Metabolism; Catechin; Cholestenones; Drugs, Chinese Herbal; Enzyme Assays; Flavanones; Glucosides; Humans; Molecular Docking Simulation; Obesity; Pancreatic alpha-Amylases; Swine; Weight Loss | 2020 |